Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Lemaitre Vascular
(NQ:
LMAT
)
106.01
+0.99 (+0.94%)
Streaming Delayed Price
Updated: 11:59 AM EST, Dec 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Lemaitre Vascular
< Previous
1
2
3
Next >
Novocure Stock Earns 96 RS Rating
December 03, 2024
On Tuesday, Novocure stock got a positive adjustment to its Relative Strength (RS) Rating to 96, up from 73.
Via
Investor's Business Daily
ResMed Is 80 And 80: Hits 80-Plus Relative Strength Rating After Rising 80% In A Year
November 18, 2024
ResMed also boasts a superb 96 EPS Rating out of 99, putting it in the top 4% of all companies for recent and long-term profit growth.
Via
Investor's Business Daily
Apple To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Friday
November 01, 2024
Via
Benzinga
In-Depth Examination Of 4 Analyst Recommendations For LeMaitre Vascular
November 01, 2024
Via
Benzinga
This Synopsys Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
October 15, 2024
Via
Benzinga
Analyst Scoreboard: 4 Ratings For LeMaitre Vascular
October 15, 2024
Via
Benzinga
Navigating 4 Analyst Ratings For LeMaitre Vascular
May 31, 2024
Via
Benzinga
Recap: LeMaitre Vascular Q4 Earnings
February 27, 2024
Via
Benzinga
Earnings Scheduled For February 27, 2024
February 27, 2024
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million.
Via
Benzinga
LMAT Stock Earnings: LeMaitre Vascular Beats EPS, Beats Revenue for Q2 2024
August 01, 2024
LMAT stock results show that LeMaitre Vascular beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Staar Surgical Stock Earns RS Rating Upgrade
June 27, 2024
On Thursday, lens maker Staar Surgical stock had its Relative Strength (RS) Rating upgraded to 87 from 77.
Via
Investor's Business Daily
Stryker Stock Sees RS Rating Treks Higher To 71
May 29, 2024
Stryker stock saw a positive improvement to its Relative Strength (RS) Rating on Wednesday, with an increase from 63 to 71.
Via
Investor's Business Daily
Sell In May And Go Away? – April Dividend Income Report
May 27, 2024
The “Sell in May and Go Away” adage is wrong for most investors.
Via
Talk Markets
LMAT Stock Earnings: LeMaitre Vascular Beats EPS, Beats Revenue for Q1 2024
May 02, 2024
LMAT stock results show that LeMaitre Vascular beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Inspire Medical Systems Stock Sees IBD RS Rating Rise To 78
April 30, 2024
On Tuesday, Inspire Medical Systems stock earned an upgrade to its Relative Strength (RS) Rating, from 69 to 78.
Via
Investor's Business Daily
A Preview Of LeMaitre Vascular's Earnings
February 26, 2024
Via
Benzinga
5 Analysts Have This to Say About LeMaitre Vascular
October 23, 2023
Via
Benzinga
Barrington Research Maintains Outperform Rating for LeMaitre Vascular: Here's What You Need To Know
February 28, 2024
Via
Benzinga
Sidoti Events, LLC's Virtual December Small-Cap Conference
December 05, 2023
Via
ACCESSWIRE
Why LeMaitre Vascular Is A Market Leader In Core Segments: Oppenheimer Initiates With Outperform Rating
September 06, 2023
Oppenheimer has initiated coverage on LeMaitre Vascular Inc (NASDAQ: LMAT) with an Outperform rating and a
Via
Benzinga
Looking for Dividend Growth? Buy This Little-Known Healthcare Stock
September 01, 2023
The healthcare company's dividend has soared in recent years.
Via
The Motley Fool
2 Healthcare Stocks That Could Help Make You a Fortune
August 26, 2023
These companies did well for shareholders over the last 10 years and have the potential to keep the growth going.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2023
September 06, 2023
Via
Benzinga
Boston Scientific Stock Gets 81 RS Rating After Profit Pops 56% In Year
August 23, 2023
Boston Scientific stock rose from a 34.98 low on June 16, 2022, amid the bear market, to an all-time high 54.66 close on June 22 this year.
Via
Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For August 3, 2023
August 03, 2023
Via
Benzinga
Yum! Brands To Rally Around 20%? Here Are 10 Other Analyst Forecasts For Thursday
August 03, 2023
Needham raised the price target for Extreme Networks, Inc. (NASDAQ: EXTR) from $30 to $35. Needham analyst Alex Henderson maintained a Buy rating. Extreme Networks shares fell 1.7% to $29.70 in...
Via
Benzinga
3 Micro-Cap Stocks to Buy Now for Gigantic Growth Potential
June 28, 2023
The smallest stocks have been trailing their larger counterparts. Here are three top micro-cap stocks to ride the asset class' resurgence.
Via
InvestorPlace
Beat the Dow Jones With This Unstoppable Dividend Stock
June 19, 2023
The wealth created by this medical devices company for its investors over the past decade far exceeds what the Dow Jones generated.
Via
The Motley Fool
Sidoti Events, LLC's Virtual June Small-Cap Conference
June 13, 2023
Via
ACCESSWIRE
Is This Healthcare Stock a Buy for Dividend Growth Investors?
May 17, 2023
This medical device maker has crushed the S&P 500 index in the past 10 years.
Via
The Motley Fool
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.